News | April 14, 2026
Briefs: Indoco Remedies and Panacea Biotec
Panacea Biotec receives LoA from CMSS
Panacea Biotec receives LoA from CMSS
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
Highlights Mirvetuximab-based regimen promise
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing
The Stealth AXiS surgical navigation system was recently cleared by the US Food and Drug Administration (FDA) for cranial procedures in the United States
Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
Subscribe To Our Newsletter & Stay Updated
